Among those chosen to help in his move to City Hall are former Goldman Sachs Group Inc. partner Margaret Anadu, developer Jed ...

President Trump is expected to unveil plans to lower healthcare costs, which could significantly impact the pharmaceutical industry. Additionally, Pfizer's (PFE) entry into the weight-loss drug space, ...

Anti-vaccine sentiment is alive and well, especially in the U.S. And it was evident in recent weeks as drugmakers revealed ...

Technology is no longer a vertical; it’s the backbone of national security and economic strength,” Michael Kratsios, director ...

ABOUT THE AUTHOR: Todd Tiahrt, a Kansas Republican, is a former member of the House of Representatives who served on the ...

Discover why Pfizer stock may be set for a bull run by 2026 with key wins, strong Q3 earnings, and growth drivers.

Though healthcare stocks have been much more measured this year, there are bright spots there as well. The medical-device maker Medtronic (MDT) closed at its highest price since May 12, 2022, after ...

Two days before Trump changed his tune by calling for House Republicans to vote to release the Epstein files, the president ...

Five years after their celebrated collaboration on a COVID-19 vaccine, Pfizer has initiated a significant divestment, selling ...

MAGA has had it with Susie Wiles, as seen by a growing number of Trump’s supporters calling on him to replace his chief of staff.

Pfizer has officially closed on its $10 billion purchase of obesity drug maker Metsera. So what does everyone think of the ...

The executive who brought Novo Nordisk A/S’s first weight-loss shot to market is coming back as chairman of the Danish ...